Nektar Therapeutics (NKTR) Other Non Operating Income (2010 - 2026)
Nektar Therapeutics' (NKTR) quarterly Other Non Operating Income came in at -$336000.0 in Q1 2026, down 226.32% year-on-year from $266000.0 in Q1 2025, and up 17.04% quarter-over-quarter from -$405000.0 in Q4 2025.
Nektar Therapeutics (NKTR) Other Non Operating Income (2010 - 2026) Analysis & Trends
Nektar Therapeutics' Other Non Operating Income history runs 17 years deep, the most recent figure standing at -$336000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 226.32% year-over-year to -$336000.0 in Q1 2026; TTM through Mar 2026 was -$602000.0, a 91.84% increase from a year earlier, with the FY2024 full-year figure at -$7.7 million, down 749.41% from the prior year.
- Other Non Operating Income advanced to -$336000.0 in Q1 2026 per NKTR's latest filing, from -$405000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $33.4 million in Q1 2022 and bottomed at -$7.5 million in Q4 2024.
- The 5-year median for Other Non Operating Income is -$121000.0 (2025), against an average of $1.4 million.
- Across the five-year window, Other Non Operating Income soared 2190.49% in 2022 and sank 785.53% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at -$3.7 million in 2022, then soared by 129.86% to $1.1 million in 2023, then sank by 785.53% to -$7.5 million in 2024, then soared by 94.59% to -$405000.0 in 2025, then climbed by 17.04% to -$336000.0 in 2026.
- Per Business Quant, the three latest NKTR Other Non Operating Income figures stand at -$336000.0 (Q1 2026), -$405000.0 (Q4 2025), and -$121000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Nektar Therapeutics | 1.76 Bn | 1.19 Bn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -336,000.00 |
| Dec 31, 2025 | -405,000.00 |
| Sep 30, 2025 | -121,000.00 |
| Jun 30, 2025 | 260,000.00 |
| Mar 31, 2025 | 266,000.00 |
| Dec 31, 2024 | -7.49 Mn |
| Sep 30, 2024 | -120,000.00 |
| Jun 30, 2024 | -36,000.00 |
| Mar 31, 2024 | -99,000.00 |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | -335,000.00 |
| Jun 30, 2023 | -1.03 Mn |
| Mar 31, 2023 | -301,000.00 |
| Dec 31, 2022 | -3.66 Mn |
| Mar 31, 2022 | 33.43 Mn |
| Dec 31, 2021 | 12.37 Mn |
| Sep 30, 2021 | 131,000.00 |
| Jun 30, 2021 | -2.71 Mn |
| Mar 31, 2021 | -1.60 Mn |
| Dec 31, 2020 | -16.45 Mn |